（於開曼群島註冊成立並於百慕達存續之有限公司） （股份代號：8081） 截至二零二四年十二月三十一日止年度 全年業績公佈 香 港 聯 合 交 易 所 有 限 公 司（「聯 交 所」）GEM的特色 GEM之 定 位，乃 為 中 小 型 公 司 提 供 一 個 上 市 之 市 場，此 等 公 司 相 比 起 其 他 在 聯 交 所 上 市 的 公 司 帶 有 較 高 投 資 風 險。有 意 投 資 者 應 了 解 投 資 於 該 等 公 司 之 潛 在 風險，並應經過審慎周詳之考慮後方作出投資決定。 由於在GEM上市的公司普遍為中小型公司，在GEM買賣之證券可能會較於主板 買賣之證券承受較大之市場波動風險，同時無法保證在GEM買賣之證券會有高 流通量之市場。 香 港 交 易 及 結 算 所 有 限 公 司 及 聯 交 所 對 本 公 佈 之 內 容 概 不 負 責，對 其 準 確 性 或 完 整 性 亦 不 發 表 任 何 聲 明，並 明 確 表 示 概 不 就 因 本 公 佈 全 部 或 任 何 部 分 內 容 而 產生或因倚賴該等內容而引致之任何損失承擔任何責任。 本 公 佈 之 資 料 乃 遵 照 聯 交 ...

香港交易及結算所有限公司及香港聯合交易所有限公司對本公佈之內容概不負 責，對 其 準 確 性 或 完 整 性 亦 不 發 表 任 何 聲 明，並 明 確 表 示 概 不 就 因 本 公 佈 全 部 或任何部分內容而產生或因倚賴該等內容而引致之任何損失承擔任何責任。 （於開曼群島註冊成立並於百慕達存續之有限公司） （股份代號：8081） 有關截至二零二四年六月三十日止六個月中期報告的澄清公佈 茲 提 述 恆 泰 裕 集 團 控 股 有 限 公 司（「本公司」，連 同 其 附 屬 公 司 統 稱「本集團」）日 期 為 二 零 二 四 年 八 月 二 十 七 日 的 公 佈，內 容 有 關 本 公 司 截 至 二 零 二 四 年 六 月 三 十 日 止 六 個 月 的 中 期 業 績，以 及 本 公 司 截 至 二 零 二 四 年 六 月 三 十 日 止 六 個 月 的 中 期 報 告（「中期報告」）。除 文 義 另 有 所 指 外，本 公 佈 所 用 詞 彙 應 與 中 期 報 告 所 界 定者具有相同涵義。 本公司董事（「董事」）會（「董事會」）宣佈，中期報告第30頁中不慎出現以下手民之誤： 於 二 零 二 四 ...

Revenue and Income - Revenue for the six months ended 30 June 2024 increased to HK$38.072 million, up from HK$34.270 million in the same period in 2023[6] - Total revenue for the six months ended 30 June 2024 was HK$38.072 million, compared to HK$34.270 million in the same period in 2023, representing an increase of 11.1%[21][23] - Revenue from the hospitality and related services segment increased to HK$32.958 million in 2024 from HK$31.562 million in 2023, a growth of 4.4%[21][23] - Loan interest income from the money lending business rose significantly to HK$5.113 million in 2024, up from HK$2.665 million in 2023, a 91.8% increase[21][23] - Revenue from food and beverage sales in the hotel business grew to HK$19.433 million in 2024 from HK$18.254 million in 2023, a 6.5% increase[24] - Revenue from hospitality and related services in Australia increased by approximately HK$1,396,000 (4%) to HK$32,958,000 for the six months ended 30 June 2024[70] - The Group recorded interest income of approximately HK$5,113,000 from its money lending business, a significant increase from HK$2,665,000 in 2023[74] Costs and Expenses - Cost of sales for the six months ended 30 June 2024 was HK$5.577 million, compared to HK$4.835 million in 2023[6] - Administrative expenses decreased to HK$41.342 million in 2024 from HK$45.905 million in 2023[6] - Finance costs decreased to HK$3.157 million in 2024 from HK$3.933 million in 2023[6] - Total depreciation and amortization expenses increased to HK$6.408 million in 2024 from HK$5.796 million in 2023, a 10.6% rise[21][23] - Staff costs, including directors' emoluments, increased to HK$19.830 million in 2024 from HK$20.322 million in 2023, a 2.4% decrease[26] - The impairment loss on contract assets, accounts receivable, loan, and interest receivables rose to HK$6.408 million in 2024 from HK$5.796 million in 2023, a 10.6% increase[26] - Staff costs, including Directors' salaries, allowances, and bonuses, totaled approximately HK$19,831,000 for the period under review, compared to HK$20,322,000 in 2023[110] Profit and Loss - The company reported a loss before tax of HK$23.712 million for the six months ended 30 June 2024, compared to a profit of HK$46.664 million in 2023[6] - Total comprehensive income for the period was a loss of HK$25.582 million in 2024, compared to a profit of HK$75.260 million in 2023[7] - Loss per share for the six months ended 30 June 2024 was HK$0.46, compared to earnings per share of HK$0.87 in 2023[7] - The company reported a loss before tax of HK$23.712 million for the six months ended 30 June 2024, compared to a profit before tax of HK$46.664 million in the same period in 2023[21][23] - The company reported a loss attributable to shareholders of HK$23,672,000 for the six months ended 30 June 2024, compared to a profit of HK$46,743,000 in the same period in 2023[31] - The company reported a loss of approximately HKD 23,712,000 for the six months ended June 30, 2024, compared to a profit of HKD 46,664,000 in the same period in 2023, primarily due to the absence of a gain from the deemed disposal of a subsidiary in 2023[63] Assets and Liabilities - Total non-current assets decreased to HK$291,268,000 from HK$296,752,000, a decline of 1.8%[8] - Current assets decreased to HK$136,856,000 from HK$144,750,000, a decline of 5.5%[8] - Cash and cash equivalents decreased to HK$26,469,000 from HK$32,507,000, a decline of 18.6%[8] - Total current liabilities decreased to HK$86,742,000 from HK$95,958,000, a decline of 9.6%[9] - Net current assets increased to HK$50,114,000 from HK$48,792,000, an increase of 2.7%[9] - Total equity decreased to HK$291,398,000 from HK$316,980,000, a decline of 8.1%[9] - Accumulated losses increased to HK$945,428,000 from HK$882,939,000, an increase of 7.1%[10] - Consolidated reserves decreased to HK$240,402,000 from HK$297,428,000, a decline of 19.2%[11] - Total assets of the Group as of 30 June 2024 were approximately HK$428,124,000, with cash and cash equivalents of HK$1,435,000[90] - Shareholders' equity as of 30 June 2024 was approximately HK$291,962,000[91] - The Group's borrowings as of 30 June 2024 were approximately HK$74,759,000, with 60,853,000 secured and 13,906,000 unsecured[91] Cash Flow - Net cash flow from operating activities for the six months ended 30 June 2024 was HK$6,361 thousand, compared to a net cash outflow of HK$23,962 thousand in the same period in 2023[12] - Net cash flow used in investing activities for the six months ended 30 June 2024 was HK$15,298 thousand, compared to a net cash inflow of HK$34,669 thousand in the same period in 2023[12] - Net cash flow from financing activities for the six months ended 30 June 2024 was HK$3,832 thousand, compared to a net cash outflow of HK$19,313 thousand in the same period in 2023[12] - Cash and cash equivalents at the end of the period were HK$1,435 thousand, a decrease from HK$5,713 thousand at the end of the same period in 2023[12] Segment Performance - The Group has four reportable operating segments: hospitality and related services in Australia, services through network media, money lending business, and assets investments business[18] - Revenue and expenses are allocated to the reportable segments based on sales generated and expenses incurred by those segments[18] - Assets and liabilities are allocated to the reportable segments, excluding unallocated corporate assets and liabilities[18] - Segment profit/(loss) is measured using adjusted profit/(loss) before tax, which excludes bank interest income, non-lease-related finance costs, dividend income, net gains on disposals of subsidiaries, and head office and corporate expenses[18] Investments and Fair Value - Share of results of associates showed a loss of HK$9.951 million in 2024, compared to a loss of HK$7.129 million in 2023[6] - Fair value loss on financial assets at FVTPL was HK$3.714 million in 2024, compared to a loss of HK$1.027 million in 2023[6] - The fair value loss on financial assets at FVTPL increased to HK$3.714 million in 2024 from HK$1.027 million in 2023, a 261.6% increase[21][23] - The Group recorded a fair value loss on financial assets at FVTPL of approximately HK$3,714,000 for the six months ended 30 June 2024, primarily due to the decrease in the fair value of investments in listed equity securities in Hong Kong[78] - The Group recorded a fair value loss on financial assets at FVTOCI of approximately HK$503,000 for the six months ended 30 June 2024, compared to a fair value gain of approximately HK$28,466,000 in 2023[78] - World Biotech Regenerative Medical Group Limited, a significant securities investment, accounted for 6.8% of the Group's total assets as of 30 June 2024, with a fair value of HK$29,190,000[79] - The Group's investment in World Biotech, representing 3.32% equity interest, had an investment cost of HK$28,697,000 and recorded no unrealised gain or dividend income for the six months ended 30 June 2024[79] - World Biotech, founded in 2020, operates a biopharmaceutical drug development centre, a production facility, and a clinical centre under the brand BioCreatrix[80] - The Group's subsidiary, Absolutely Talent Technology Limited, invested HK$40,000,000 in World Biotech in October 2021, acquiring a 4.65% equity interest[81] - World Biotech's net profit guarantee for the two financial years ending 30 September 2025 or its valuation by 31 December 2025 must not be less than agreed amounts, or compensation will be paid to Absolutely Talent Technology Limited[82] - The Group recorded a gain of approximately HK$335,000 from the disposal of 25,000 shares of World Biotech during the six months ended 30 June 2023[82] - As of 30 June 2024, the Group's 35,650 shares (3.32% equity) in World Biotech and the Profit Guarantee had an aggregate fair value of approximately HK$29,190,000, representing 6.8% of the Group's total assets[82] - World Biotech completed the construction of a GMP-compliant production plant in 2023, enabling it to manufacture clinical trial products and distribute bi-products globally[82] - The Group held 10,650 ordinary shares (48.33% equity) in Luck Key Investment Limited as of 30 June 2024, with a carrying amount of approximately HK$60,740,000, representing 14.2% of the Group's total assets[83] - Luck Key's revenue for the period under review decreased by 18% to approximately HK$94,879,000, with a loss attributable to shareholders of approximately HK$19,821,000[84] - Luck Key Group operates 11 health check centers and 2 laboratories in Hong Kong, providing a wide range of medical diagnostic and health check services[83] - The Group plans to continue holding its investments unless changes in strategy or opportunities to realize existing investments arise, aiming to optimize returns and create value for shareholders[85] Borrowings and Financial Instruments - Total interest-bearing borrowings increased to HK$74,759,000 as of 30 June 2024 from HK$65,959,000 as of 31 December 2023[51] - Fixed-rate borrowings increased to HK$13,906,000 as of 30 June 2024 from HK$10,188,000 as of 31 December 2023[51] - Variable-rate borrowings increased to HK$60,853,000 as of 30 June 2024 from HK$55,771,000 as of 31 December 2023[51] - Effective interest rates for fixed-rate borrowings ranged from 10.00% to 11.00% as of 30 June 2024, compared to 6.00% to 11.00% as of 31 December 2023[52] - The company issued convertible notes with a total principal amount of HKD 7,600,000, with an extended maturity date of September 30, 2024. The notes can be converted into ordinary shares of EFL or redeemed at 105% of the face value starting from March 31, 2023[54] - The liability component of the convertible notes increased from HKD 7,715,613 as of January 1, 2023, to HKD 8,328,373 as of December 31, 2023, and further to HKD 8,358 as of June 30, 2024[54] - The Group's borrowings repayable within one year as of 30 June 2024 were approximately HK$24,799,000, with interest rates ranging from 7.23% to 11.00%[90] - The Group's gearing ratio as of 30 June 2024 was 0.32 times, and its net debt-to-equity capital ratio was 0.43 times[90] - Effective interest rates on fixed-rate borrowings ranged from 10.00% to 11.00%, and on variable-rate borrowings from 7.23% to 7.40% as of 30 June 2024[94] - The Group's borrowing facilities as of 30 June 2024 were approximately HK$93,452,000, with HK$74,759,000 utilized[90] - Certain borrowing facilities were secured by freehold land and buildings valued at approximately HK$82,373,000 as of 30 June 2024[96] - Subsidiary EFL issued convertible loan notes totaling HKD 7.6 million for general working capital, with an extended maturity date of September 30, 2024[124] - As of June 30, 2024, HKD 300,000 of the convertible loan notes were redeemed, and no conversions occurred[124] - The outstanding principal amount of convertible notes as of 30 June 2024 was HK$7,300,000, down from HK$7,600,000 as of 31 December 2023[121] - The convertible notes issued by EFL have a maturity date of 30 September 2024 and can be converted into ordinary shares of EFL[121] - The full exercise of the conversion right for the outstanding convertible notes would not result in the issuance of more than 5% of EFL's existing issued shares[121] - Noteholders can request early redemption of the convertible notes at 105% of the par value from the first business day after 31 March 2023 to 10 business days before the maturity date[121] Legal and Contingent Liabilities - Ever Robust Holdings Limited, a subsidiary, is involved in legal proceedings with Convoy Global Holdings Limited, seeking orders to set aside share allotments and rescind financing facilities, including a HK$129,000,000 loan and a HK$67,574,473 margin loan[100] - Ever Robust fully repaid the HK$129,000,000 loan and HK$67,574,473 margin loan by 19 December 2017 and no longer holds shares in Convoy[100] - On 6 March 2018, a case management conference was held for the Convoy Proceedings, with amended claims seeking declarations of nullity for share allotments and orders for damages and equitable compensation[101][103] - On 27 July 2018, Ever Robust received a sealed order allowing the Plaintiffs to file and serve an amended statement of claim, with 11 additional parties ordered to join the proceedings[102] - Ever Robust filed its defense on 10 December 2018, asserting that the Plaintiffs are not entitled to any relief in the Convoy Proceedings[104] - On 2 January 2018, Ever Robust received a petition from Zhu Xiao Yan seeking orders to declare share placements void and claim damages for shareholding dilution, with Ever Robust holding no shares in Convoy as of that date[105] - The Zhu Proceedings were stayed on 6 March 2018 pending the outcome of the Convoy Proceedings[106] - The Group did not have any material contingent liabilities as of 30 June 2024, the same as in 2023[109][113] - The Group has not made any provisions for legal proceedings due to the inability to reliably assess potential liabilities[108][112] Corporate Governance and Shareholder Information - The company's authorized share capital is 20,000,000,000 ordinary shares with a nominal value of HKD 0.01 each, and the issued and fully paid shares as of June 30, 2024, were 5,156,035,108 shares[55] - Ng Ting Kit holds a 9.64% beneficial interest in the company's shares, totaling 497,180,000 shares[120] - King's Group Capital Limited, wholly owned by Ng Ting Kit, holds a 5.06% interest in the company's shares, totaling 260,800,000 shares[120] - The total issued shares of the company as of 30 June 2024 were 5,156,035,108[120] - No share options were outstanding as of 30 June 2024, compared to none as of 31 December 2023[119] - The maximum entitlement for each participant under the share option scheme does not exceed 1% of the aggregate number of shares issued and issuable in any 12-month period[126][129] - The share option scheme allows for a nominal consideration of HKD 1 upon acceptance of the grant[126][129] - The exercise price of options cannot be less than the highest of the closing price on the grant date, the average closing price for the preceding five trading days, or the nominal value of the shares[127][129] - The share option scheme remains in force for 10 years from its adoption date of June 9, 2020[127][129] - As of January 1, 2024, and June 30, 2024, 533,623,510 shares were available for grant under the scheme, representing approximately 10.35% of the issued share capital[127][129] - No options were granted under the scheme during the six months ended June 30, 2024[127][129] - There were no outstanding, granted, exercised, canceled, or lapsed share options under the scheme as of January 1, 2024, and June 30, 2024[128][129] - Non-executive Director Mr. Ng Ting Ho holds directorships in Way Union Finance Limited and Delight Sky Finance Limited, which are engaged in money lending business in Hong Kong[131] - The company has established an Audit Committee consisting of three independent non-executive directors, with Mr. Wong Siu Keung, Joe serving as the chairman during the review period[135] - The Audit Committee reviewed the Group's unaudited condensed consolidated results for the six months ended 30 June 2024 and confirmed compliance with applicable accounting standards and GEM Listing Rules[135] - The Board of Directors includes one

Financial Performance - For the six months ended June 30, 2024, the Group reported revenue of HK$38,072,000, an increase of 11.8% compared to HK$34,270,000 in the same period of 2023[7]. - The Group incurred a loss before tax of HK$23,712,000, compared to a profit before tax of HK$46,664,000 in the corresponding period of 2023[7]. - The loss for the period was HK$23,712,000, contrasting with a profit of HK$46,664,000 in the same period last year[7]. - For the six months ended June 30, 2024, the company reported a total comprehensive loss of HK$25,582, compared to a profit of HK$75,260 for the same period in 2023, representing a significant decline[8]. - The loss attributable to shareholders for the period was HK$23,672, a decrease from a profit of HK$46,743 in the prior year, indicating a year-over-year decline of approximately 150%[8]. - Basic and diluted loss per share was HK$0.46, compared to earnings of HK$0.87 per share in the previous year, reflecting a substantial decrease in profitability[8]. Expenses and Costs - Administrative expenses decreased to HK$41,342,000 from HK$45,905,000, reflecting a reduction of approximately 10%[7]. - The Group's finance costs decreased to HK$3,157,000 from HK$3,933,000, indicating a reduction of about 19.7%[7]. - Other income and gains amounted to HK$2,120,000, down from HK$2,946,000 in the previous year[7]. - The profit before tax for the period was impacted by an impairment loss on contract assets and accounts receivable amounting to HK$6,408,000, compared to HK$5,796,000 in 2023[27]. Assets and Liabilities - Total current assets decreased to HK$136,856 from HK$144,750 as of December 31, 2023, marking a decline of approximately 5.7%[9]. - Non-current assets totaled HK$291,268, a slight decrease from HK$296,752 at the end of 2023, representing a decline of approximately 1.6%[9]. - Total liabilities increased, with current liabilities rising to HK$86,742 from HK$95,958, a decrease of about 9.6%[10]. - The company reported a decrease in cash and cash equivalents to HK$26,469 from HK$32,507, reflecting a decline of approximately 18.5%[9]. - The accumulated losses as of June 30, 2024, were HK$945,428,000, compared to HK$848,739,000 as of June 30, 2023[11]. Cash Flow - For the six months ended June 30, 2024, the net cash flow from operating activities was HK$6,361,000, compared to a net cash outflow of HK$23,962,000 in the same period of 2023[13]. - The net cash flow used in investing activities was HK$15,298,000 for the six months ended June 30, 2024, a decrease from a net cash inflow of HK$34,669,000 in 2023[13]. - The net cash flow from financing activities was HK$3,832,000 for the six months ended June 30, 2024, compared to a net cash outflow of HK$19,313,000 in 2023[13]. Segment Performance - For the six months ended June 30, 2024, total segment revenue was HK$38,072,000, with hospitality services contributing HK$32,958,000, money lending HK$5,113,000, and network media services HK$1,000[22]. - The segment profit for hospitality services was a loss of HK$1,620,000, while money lending generated a profit of HK$194,000, and network media services incurred a loss of HK$69,000, resulting in a total segment loss of HK$13,918,000[22]. - Revenue from contracts with customers in hospitality and related services was HK$13,525,000, up from HK$13,308,000, reflecting a growth of 1.6%[25]. - Loan interest income significantly increased to HK$5,113,000, compared to HK$2,665,000 in the previous year, marking a growth of 92.5%[25]. Investments - The Group's financial assets at fair value through profit or loss (FVTPL) totaled HK$55,659,000 as of June 30, 2024, compared to HK$61,697,000 as of December 31, 2023, indicating a decline of about 9.8%[40]. - The Group's investment portfolio mainly comprised securities issued by listed companies, with a fair value loss on financial assets at FVTOCI of approximately HK$503,000 for the six months ended June 30, 2024, compared to a fair value gain of approximately HK$28,466,000 in 2023[79]. - The Group holds a 3.32% equity interest in World Biotech, with an investment cost of HK$28,697,000[80]. - The investment in Luck Key Investment Limited represents approximately 48.33% equity interest, with a carrying amount of approximately HK$60,740,000 as of June 30, 2024, accounting for about 14.2% of the Group's total assets[84]. Legal Proceedings - The Group was involved in legal proceedings related to claims against its subsidiary, Ever Robust, with a loan amount of HK$129,000,000 and a margin loan of HK$67,574,473 being contested[101]. - The Group has not made any provisions for the legal proceedings as it is unable to reliably assess the amount of potential liabilities[109]. - The Group's legal proceedings include claims related to share placements and potential damages for dilution of shareholding[106]. Corporate Governance - The Audit Committee consists of three independent non-executive Directors, ensuring compliance with GEM Listing Rules and corporate governance standards[135]. - The Company is committed to good corporate governance practices, enhancing transparency and quality of disclosure[135]. - The Company has complied with the Corporate Governance Code provisions during the review period[134].

CHARACTERISTICS OF GEM OF THE STOCK EXCHANGE OF HONG KONG LIMITED ("STOCK EXCHANGE") GEM has been positioned as a market designed to accommodate small and mid-sized companies to which a higher investment risk may be attached than other companies listed on the Stock Exchange. Prospective investors should be aware of the potential risks of investing in such companies and should make the decision to invest only after due and careful consideration. Given that the companies listed on GEM are generally small and ...

香港交易及結算所有限公司及香港聯合交易所有限公司對本公佈之內容概不負 責，對 其 準 確 性 或 完 整 性 亦 不 發 表 任 何 聲 明，並 明 確 表 示 概 不 就 因 本 公 佈 全 部 或任何部分內容而產生或因倚賴該等內容而引致之任何損失承擔任何責任。 （於開曼群島註冊成立並於百慕達存續之有限公司） （股份代號：8081） 截至二零二三年十二月三十一日止年度 全年業績公佈 恆泰裕集團控股有限公司（「本公司」，連同其附屬公司稱為「本集團」）董事（「董事」） 會（「董事會」）欣然公佈本集團截至二零二三年十二月三十一日止年度之全年業績。 本 公 佈 載 有 本 公 司 二 零 二 三 年 年 度 報 告 全 文，乃 符 合 香 港 聯 合 交 易 所 有 限 公 司 GEM證 券 上 市 規 則（「GEM上市規則」）中 有 關 全 年 業 績 初 步 公 佈 附 載 資 料 之 相 關 要求。 代表董事會 恆泰裕集團控股有限公司 主 席 吳廷浩 二零二四年三月二十八日 於 本 公 佈 日 期，董 事 會 成 員 包 括(i)一 名 非 執 行 董 事，即 吳 廷 浩 先 生；(ii)兩名執 行董事，即林 ...

| --- | --- | |----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------- ...

香港交易及結算所有限公司及香港聯合交易所有限公司對本公佈之內容概不負 責，對其準確性或完整性亦不發表任何聲明，並明確表示概不就因本公佈全部 或任何部分內容而產生或因倚賴該等內容而引致之任何損失承擔任何責任。 （於開曼群島註冊成立並於百慕達存續之有限公司） （股份代號：8081） 二零二三年第三季度業績公佈 恆泰裕集團控股有限公司（「本公司」，連同其附屬公司稱為「本集團」）董事（「董事」） 會（「董事會」）欣然公佈本集團截至二零二三年九月三十日止九個月之未經審核 業績。本公佈載有本公司二零二三年第三季度報告全文，乃符合香港聯合交易 所有限公司GEM證券上市規則（「GEM上市規則」）中有關第三季度業績初步公佈 之附載資料之相關要求。 代表董事會 恆泰裕集團控股有限公司 主席 吳廷浩 香港，二零二三年十一月十日 於本公佈日期，董事會成員包括(i)一名非執行董事，即吳廷浩先生；(ii)兩名執 ...

CHARACTERISTICS OF GEM OF THE STOCK EXCHANGE OF HONG KONG LIMITED ("STOCK EXCHANGE") GEM has been positioned as a market designed to accommodate small and mid-sized companies to which a higher investment risk may be attached than other companies listed on the Stock Exchange. Prospective investors should be aware of the potential risks of investing in such companies and should make the decision to invest only after due and careful consideration. Given that the companies listed on GEM are generally small and ...

香港交易及結算所有限公司及香港聯合交易所有限公司對本公佈之內容概不負 責，對其準確性或完整性亦不發表任何聲明，並明確表示概不就因本公佈全部 或任何部分內容而產生或因倚賴該等內容而引致之任何損失承擔任何責任。 （於開曼群島註冊成立並於百慕達存續之有限公司） （股份代號：8081） 二零二三年中期業績公佈 恆泰裕集團控股有限公司（「本公司」，連同其附屬公司稱為「本集團」）董事（「董事」） 會（「董事會」）欣然公佈本集團截至二零二三年六月三十日止六個月之未經審核 業績。本公佈載有本公司二零二三年中期報告全文，乃符合香港聯合交易所有 限公司GEM證券上市規則（「GEM上市規則」）中有關中期業績初步公佈之附載資料。 代表董事會 恆泰裕集團控股有限公司 主席 吳廷浩 香港，二零二三年八月十一日 於本公佈日期，董事會成員包括(i)一名非執行董事，即吳廷浩先生；(ii)兩名執 行董事，即林靜儀女士及方澤翹先生；及(iii)三名獨立非執行董事，即黃兆強先生、 ...